TaiMed Biologics Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Cash & Equivalents	703.55	580.23	251.01	274.11	551.62	572.09	Upgrade
Short-Term Investments	945.97	1,072	395.49	309.93	406.68	629	Upgrade
Trading Asset Securities	-	-	-	58.75	-	-	Upgrade
Cash & Short-Term Investments	1,650	1,652	646.5	642.79	958.3	1,201	Upgrade
Cash Growth	-23.10%	155.58%	0.58%	-32.92%	-20.21%	-5.57%	Upgrade
Accounts Receivable	75.21	103.02	160.49	98.24	157.78	268.92	Upgrade
Other Receivables	4.43	31.3	28.16	25.49	35.41	19.69	Upgrade
Receivables	79.64	134.31	188.65	123.73	193.19	288.61	Upgrade
Inventory	890.67	1,569	1,271	1,389	1,177	1,281	Upgrade
Prepaid Expenses	-	6.41	10.01	4.15	3.54	4.73	Upgrade
Other Current Assets	631.99	31.16	35.63	5.08	2.59	2.93	Upgrade
Total Current Assets	3,252	3,394	2,151	2,165	2,335	2,778	Upgrade
Property, Plant & Equipment	836.81	857.4	908.26	957.74	1,011	1,065	Upgrade
Long-Term Investments	14.65	-	0.9	43.44	232.63	203	Upgrade
Other Intangible Assets	490.07	539.4	625.79	724.38	821.33	940.16	Upgrade
Other Long-Term Assets	206.91	208.79	207.58	210.57	211.19	210.59	Upgrade
Total Assets	4,800	4,999	3,894	4,101	4,611	5,196	Upgrade
Accounts Payable	4.2	0.76	13.5	0.09	122.58	6.16	Upgrade
Accrued Expenses	-	11.63	7.49	39.39	51.64	361.04	Upgrade
Short-Term Debt	-	-	200	200	-	-	Upgrade
Current Portion of Long-Term Debt	27.54	27.24	26.97	14.32	-	-	Upgrade
Current Portion of Leases	2.27	2.26	2.18	2.02	1.95	1.93	Upgrade
Current Unearned Revenue	69.64	74.32	91.12	57.48	24.34	37.59	Upgrade
Other Current Liabilities	29.7	18.56	19.92	16.57	24.57	54.81	Upgrade
Total Current Liabilities	133.34	134.77	361.17	329.86	225.08	461.52	Upgrade
Long-Term Debt	454.18	468.03	495.04	521.68	536	536	Upgrade
Long-Term Leases	23.96	25.1	26.67	28.12	29.38	31.32	Upgrade
Long-Term Unearned Revenue	266.56	347.53	444.04	505.6	877.9	750.74	Upgrade
Other Long-Term Liabilities	0.92	0.92	0.92	0.92	0.87	0.86	Upgrade
Total Liabilities	878.96	976.34	1,328	1,386	1,669	1,780	Upgrade
Common Stock	2,732	2,731	2,530	2,526	2,523	2,522	Upgrade
Additional Paid-In Capital	2,463	2,452	986.67	945.45	925.14	4,832	Upgrade
Retained Earnings	-1,222	-1,136	-934.56	-740.22	-470.93	-3,921	Upgrade
Comprehensive Income & Other	-51.72	-23.89	-16.13	-15.83	-35.97	-17.6	Upgrade
Shareholders' Equity	3,921	4,023	2,566	2,715	2,942	3,416	Upgrade
Total Liabilities & Equity	4,800	4,999	3,894	4,101	4,611	5,196	Upgrade
Total Debt	507.95	522.63	750.86	766.14	567.32	569.25	Upgrade
Net Cash (Debt)	1,142	1,130	-104.35	-123.35	390.98	631.84	Upgrade
Net Cash Growth	-29.00%	-	-	-	-38.12%	-48.96%	Upgrade
Net Cash Per Share	4.11	4.21	-0.41	-0.49	1.55	2.51	Upgrade
Filing Date Shares Outstanding	270.23	273.08	253.01	252.55	252.33	252.22	Upgrade
Total Common Shares Outstanding	270.23	273.08	253.01	252.55	252.33	252.22	Upgrade
Working Capital	3,118	3,259	1,790	1,835	2,110	2,316	Upgrade
Book Value Per Share	14.51	14.73	10.14	10.75	11.66	13.54	Upgrade
Tangible Book Value	3,431	3,484	1,940	1,991	2,120	2,476	Upgrade
Tangible Book Value Per Share	12.70	12.76	7.67	7.88	8.40	9.82	Upgrade
Land	-	194.61	194.61	194.61	194.61	194.61	Upgrade
Buildings	-	495.41	493.95	493.54	493.12	492.72	Upgrade
Machinery	-	457.35	455.56	450.03	446.9	443.66	Upgrade
Leasehold Improvements	-	4.64	4.64	4.64	4.64	4.64	Upgrade

Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.